Chemotherapy Induced
Myelosuppression
Treatment Market
Share, Global Trends,
Analysis, Research, Report,
Opportunities,
Segmentation and Forecast,
2016
Future Market Insights
www.futuremarketinsights.com
[email protected]
Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting
services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,
technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.
We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and
Retail.
We have a global presence with delivery centers across India specializing in providing global research reports and country
research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.
We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for
our client.
Research Capabilities
Sector Coverage








Customized Research
Syndicated Research
Investment Research
Social Media Research
Automotive and Transportation
Electronics, Semiconductor, and ICT
Retail and Consumer Products
Industrial Automation and Equipment
Customized
Research
Subscription Information
Syndicated
Research
For detailed subscription information please contact
Investment
Research
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268
Social Media
Research
Hari. T (Sr. Manager - Global Business Development)
Email: [email protected]




Chemicals & Materials
Food and Beverages
Services and Utilities
Energy, Mining, Oil, and Gas
Report
Description
Report Description
Myelosuppression is a painless condition in which depletion of blood cells, results in
anemia, neutropenia and thrombocytopenia. Myelosuppression is bone marrow
suppression. The blood cells that are formed in the bone marrow are found to be
reduced in myelosuppression. Myelosuppression is the most common side effect of the
cancer chemotherapy treatment. Thus, it is commonly found in cancer patients. These
conditions leads to fatigue, excessive bleeding and increased risk of infections.
Myelosuppression is usually a temporary condition but the irreversible damage to the
bone marrow may cause permanent myelosuppression.Myelosuppression is commonly
managed by reducing the dose or modification of chemotherapy that allows the recovery
of hematopoietic activity.
Chemotherapy Induced Myelosuppression Treatment Market: Drivers and Restraints
The major factor driving the growth of chemotherapy induced myelosuppression market
is increasing incidence of cancer. According to World Health Organization, approximately
8.2 Mn deaths were reported due to cancer in the year 2012. Also, it is predicted that
annual cancer cases will rise from 14 Mn to 22 Mn in next two decades. In addition, it is
stated by National Cancer Institute that there were approximately 1,660,290 cases
reported in the U.S. in 2013. Increasing incidences of cancer increases the risk of
myelosuppression and hence is anticipated to drive market growth during the forecast
period. However, less number of commercially available drugs for the treatment of
myelosuppression may restrain the market growth.
Report
Description
Report Description
Request free sample Report: http://www.futuremarketinsights.com/reports/sample/repgb-1364
Chemotherapy Induced Myelosuppression Treatment Market: Segmentation
The global chemotherapy induced myelosuppression treatment market has been
classified on the basis of product type, end use and geography.
Based on product type, the global chemotherapy induced myelosuppression treatment
market is divided into following:
• Granulocyte Colony-Stimulating Factor (G-CSF)
• Recombinant human erythropoietin erythropoiesis-stimulating agents (ESAs)
• Granulocyte-macrophage colony-stimulating factor (GM-CSF)
• Antibiotics
• Thrombopoietic Agents
• Peripheral Blood Stem Cells
Based on end user type, the global chemotherapy induced myelosuppression treatment
market is divided into following:
• Hospitals
• Clinics
Report
Description
Report Description
• Cancer rehabilitation centers
Chemotherapy Induced Myelosuppression Treatment Market: Overview
Due to the availability of variety of chemotherapeutic agents for cancer treatment, the
risk of myelosuppression is expected to increase significantly. Thus, pharmaceutical and
biopharmaceutical industries are focusing on the research and development of
myelosuppression treatment. The Granulocyte Colony-Stimulating Factor (G-CSF) and
Granulocyte-macrophage colony-stimulating factor (GM-CSF) segments are projected to
collectively hold a major share owing to the patient’s effective response by these
therapies. The first line of treatment for chemotherapy induced myelosuppression is
reducing the dose of chemotherapeutic agents though the chemotherapy is continued
for the treatment of cancer.
Request for TOC: http://www.futuremarketinsights.com/toc/rep-gb-1364
Chemotherapy Induced Myelosuppression Treatment Market: Regional Overview
Geographically, the global chemotherapy induced myelosuppression treatment market is
classified into regions namely, North America, Latin America, Western Europe, Eastern
Europe, Asia-Pacific, Japan, Middle East and Africa. U.S. is the largest chemotherapy
induced myelosuppression market while Europe is considered as the second largest
market for chemotherapy induced myelosuppression. Large patient base with increasing
geriatric population in these regions drives the growth of this market.
Report
Description
Report Description
The market of chemotherapy induced myelosuppression in APAC is expected to grow at a
rapid pace owing to a rise in total number of newly diagnosed patient population in this
region. According to World Health Organization, 60% of the world’s total annual cases of
cancer occur in Africa, Asia and Latin America which is anticipated to boost market
growth in the regions.
Chemotherapy Induced Myelosuppression Treatment Market: Key Players
Some of the key players in chemotherapy induced myelosuppression market are Novartis
Pharmaceuticals, Merc & Co., Inc., Bristol-Myers Squibb Company, AbbVie Inc., Celgen
Corporation, Amgen Inc., Teva pharmaceutical Industries Ltd., Biocon, Emcure
Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Dr. Reddy’s Laboratories Ltd., and
Abbott.
Browse full report: http://www.futuremarketinsights.com/reports/chemotherapyinduced-myelosuppression-treatment-market
Thank You!
To know more about us, please visit our website:
www.futuremarketinsights.com
For sales queries or new topics email us on:
[email protected]
For other queries contact: Mr. Sudip Saha
Future Market Insights: 616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
T: +1-347-918-3531 | D: +1-845-579-5705